Bluejay Diagnostics Correlations
BJDX Stock | USD 4.40 0.33 8.11% |
The current 90-days correlation between Bluejay Diagnostics and Bone Biologics Corp is -0.17 (i.e., Good diversification). The correlation of Bluejay Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Bluejay Diagnostics Correlation With Market
Good diversification
The correlation between Bluejay Diagnostics and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
Bluejay |
Moving against Bluejay Stock
0.43 | ELMD | Electromed Potential Growth | PairCorr |
0.4 | DH | Definitive Healthcare Buyout Trend | PairCorr |
0.37 | DXCM | DexCom Inc | PairCorr |
0.37 | ECOR | Electrocore LLC | PairCorr |
0.32 | EKSO | Ekso Bionics Holdings | PairCorr |
0.4 | DVA | DaVita HealthCare | PairCorr |
0.39 | FONR | Fonar | PairCorr |
0.39 | FORA | Forian Inc Earnings Call This Week | PairCorr |
0.38 | BSX | Boston Scientific Corp | PairCorr |
0.37 | XAIR | Beyond Air | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bluejay Stock performing well and Bluejay Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bluejay Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BBLG | 3.63 | (0.18) | 0.00 | (0.36) | 0.00 | 10.13 | 23.26 | |||
TLIS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
NUWE | 3.58 | 0.41 | 0.09 | 0.15 | 3.71 | 10.62 | 20.78 | |||
HSCS | 3.04 | (0.07) | 0.00 | (2.38) | 0.00 | 7.14 | 19.85 | |||
TIVC | 10.43 | 1.84 | 0.23 | (3.89) | 7.77 | 13.08 | 221.76 | |||
NXL | 5.48 | (0.07) | 0.00 | (0.12) | 0.00 | 10.77 | 29.64 | |||
INVO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MOTS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IRIX | 3.27 | (0.59) | 0.00 | (0.41) | 0.00 | 8.93 | 31.26 |
Bluejay Diagnostics Corporate Management
Kenneth CPA | Chief Officer | Profile | |
Kevin Vance | Chief Officer | Profile | |
Jason Cook | Chief Officer | Profile | |
Mark MD | Chief Advisor | Profile | |
Les DeLuca | Vice Operations | Profile | |
Eryn Graham | Marketing Manager | Profile |